Clinical Trial Update: A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 gene transfer study aimed at inducing fetal hemoglobin for sickle cell disease (GRASP, BMT CTN 2001). The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: David Williams | Conditions: Sickle Cell Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING